Catalyst Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Catalyst Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker CPRX.
Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables, Florida, operates as a commercial-stage biopharmaceutical enterprise. This company is dedicated to discovering, developing, and marketing therapeutic solutions for individuals in the United States who are afflicted with uncommon, severe, and long-term neuromuscular and neurological disorders. Among its key offerings is Firdapse, an...
Can you invest in Catalyst Pharmaceuticals, Inc.?
Yes. Catalyst Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker CPRX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Catalyst Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.